Review



s ketamine  (Pfizer Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Pfizer Inc s ketamine
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    S Ketamine, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine/product/Pfizer Inc
    Average 86 stars, based on 1 article reviews
    s ketamine - by Bioz Stars, 2026-05
    86/100 stars

    Images

    1) Product Images from "Antidepressants interact with sex steroid receptors and their intracellular signaling components"

    Article Title: Antidepressants interact with sex steroid receptors and their intracellular signaling components

    Journal: bioRxiv

    doi: 10.64898/2026.03.17.712321

    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment with S-ketamine (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    Figure Legend Snippet: Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment with S-ketamine (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).

    Techniques Used: Phospho-proteomics, Control, Sandwich ELISA, Positive Control, Activation Assay, Inhibition, Concentration Assay, Western Blot, Membrane

    Antidepressants selectively activate MAPK signaling and induce ERα-dependent gene expression in MCF-7 cells. (A) Quantification of MAPK phosphorylation (pMAPK/MAPK) by Western blot densitometry following treatment with vehicle, imipramine, S-ketamine, or estradiol (E2), in the presence or absence of the ERα degrader/antagonist fulvestrant and/or tunicamycin. Antidepressant treatment significantly increased MAPK phosphorylation, indicating enhanced MAPK pathway activation. (B) Total MAPK levels normalized to β-actin were unchanged across treatment conditions. Representative immunoblots for MAPK and pMAPK are shown above. (C) Quantification of Akt phosphorylation (pAkt/Akt) revealed no significant changes following antidepressant or E2 treatment, but there was a trend for a reduction by imipramine. (D) Total Akt levels normalized to β-actin were unaltered. Representative immunoblots for Akt and pAkt are shown above. One imipramine-treated sample was excluded from analysis due to an outlier pMAPK/MAPK ratio exceeding 1. Data from technical and biological replicates were pooled. (E–F) mRNA expression of the extranuclear-initiated ERα target gene LRRC54 (E) and the classical nuclear ERα target gene PgR (F) , quantified by qPCR following treatment with E2, imipramine, or S-ketamine. Antidepressants significantly increased LRRC54 and PgR expression, comparable to E2 and relative to vehicle control. Pretreatment with fulvestrant attenuated these effects, indicating ERα dependency. Data are presented as mean ± SEM from three independent biological replicates (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and ns as not significant.
    Figure Legend Snippet: Antidepressants selectively activate MAPK signaling and induce ERα-dependent gene expression in MCF-7 cells. (A) Quantification of MAPK phosphorylation (pMAPK/MAPK) by Western blot densitometry following treatment with vehicle, imipramine, S-ketamine, or estradiol (E2), in the presence or absence of the ERα degrader/antagonist fulvestrant and/or tunicamycin. Antidepressant treatment significantly increased MAPK phosphorylation, indicating enhanced MAPK pathway activation. (B) Total MAPK levels normalized to β-actin were unchanged across treatment conditions. Representative immunoblots for MAPK and pMAPK are shown above. (C) Quantification of Akt phosphorylation (pAkt/Akt) revealed no significant changes following antidepressant or E2 treatment, but there was a trend for a reduction by imipramine. (D) Total Akt levels normalized to β-actin were unaltered. Representative immunoblots for Akt and pAkt are shown above. One imipramine-treated sample was excluded from analysis due to an outlier pMAPK/MAPK ratio exceeding 1. Data from technical and biological replicates were pooled. (E–F) mRNA expression of the extranuclear-initiated ERα target gene LRRC54 (E) and the classical nuclear ERα target gene PgR (F) , quantified by qPCR following treatment with E2, imipramine, or S-ketamine. Antidepressants significantly increased LRRC54 and PgR expression, comparable to E2 and relative to vehicle control. Pretreatment with fulvestrant attenuated these effects, indicating ERα dependency. Data are presented as mean ± SEM from three independent biological replicates (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and ns as not significant.

    Techniques Used: Gene Expression, Phospho-proteomics, Western Blot, Activation Assay, Expressing, Control

    Time-dependent structural changes over 100 ns trajectories for ERα complexed with estradiol, imipramine, fluoxetine, S-ketamine, PaPE-1, and hydroxynorketamine (HNK). ( A ) Ligand root mean square deviation (RMSD) relative to the initial equilibrated structure, characterizing the stability and mobility of each compound within the binding pocket. ( B ) Protein backbone Cα RMSD, demonstrating the global structural integrity and stability of the receptor across all systems. ( C ) Cα root mean square fluctuation (RMSF) per residue, illustrating local protein flexibility and conserved dynamic patterns across the ligand-binding domain. ( D ) Radius of gyration (Rg) and its principal components (X, Y, Z), representing the maintenance of global structural compactness and shape. ( E ) Solvent accessible surface area (SASA) of the protein–ligand complexes, indicating stable exposure of the receptor-ligand surface throughout the simulation. ( F ) Visual representation of comparative binding free energies for the compounds based on MM/PBSA and MM/GBSA methods.
    Figure Legend Snippet: Time-dependent structural changes over 100 ns trajectories for ERα complexed with estradiol, imipramine, fluoxetine, S-ketamine, PaPE-1, and hydroxynorketamine (HNK). ( A ) Ligand root mean square deviation (RMSD) relative to the initial equilibrated structure, characterizing the stability and mobility of each compound within the binding pocket. ( B ) Protein backbone Cα RMSD, demonstrating the global structural integrity and stability of the receptor across all systems. ( C ) Cα root mean square fluctuation (RMSF) per residue, illustrating local protein flexibility and conserved dynamic patterns across the ligand-binding domain. ( D ) Radius of gyration (Rg) and its principal components (X, Y, Z), representing the maintenance of global structural compactness and shape. ( E ) Solvent accessible surface area (SASA) of the protein–ligand complexes, indicating stable exposure of the receptor-ligand surface throughout the simulation. ( F ) Visual representation of comparative binding free energies for the compounds based on MM/PBSA and MM/GBSA methods.

    Techniques Used: Binding Assay, Residue, Ligand Binding Assay, Solvent



    Similar Products

    s ketamine  (Janssen)
    86
    Janssen s ketamine
    S Ketamine, supplied by Janssen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine/product/Janssen
    Average 86 stars, based on 1 article reviews
    s ketamine - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    s ketamine  (Pfizer Inc)
    86
    Pfizer Inc s ketamine
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    S Ketamine, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine/product/Pfizer Inc
    Average 86 stars, based on 1 article reviews
    s ketamine - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ketamine ketanest s  (Pfizer Inc)
    86
    Pfizer Inc ketamine ketanest s
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    Ketamine Ketanest S, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ketamine ketanest s/product/Pfizer Inc
    Average 86 stars, based on 1 article reviews
    ketamine ketanest s - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    nasal spray releases s ketamine  (Janssen)
    86
    Janssen nasal spray releases s ketamine
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    Nasal Spray Releases S Ketamine, supplied by Janssen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nasal spray releases s ketamine/product/Janssen
    Average 86 stars, based on 1 article reviews
    nasal spray releases s ketamine - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    s ketamine hydrochloride  (Daiichi Sankyo)
    86
    Daiichi Sankyo s ketamine hydrochloride
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    S Ketamine Hydrochloride, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine hydrochloride/product/Daiichi Sankyo
    Average 86 stars, based on 1 article reviews
    s ketamine hydrochloride - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    s ketamine exposure reduces mbp expression  (Dawley Inc)
    86
    Dawley Inc s ketamine exposure reduces mbp expression
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    S Ketamine Exposure Reduces Mbp Expression, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine exposure reduces mbp expression/product/Dawley Inc
    Average 86 stars, based on 1 article reviews
    s ketamine exposure reduces mbp expression - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    s ketamine ketalar 200 mg 20 ml daiichi sankyo tokyo japan  (Daiichi Sankyo)
    86
    Daiichi Sankyo s ketamine ketalar 200 mg 20 ml daiichi sankyo tokyo japan
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    S Ketamine Ketalar 200 Mg 20 Ml Daiichi Sankyo Tokyo Japan, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine ketalar 200 mg 20 ml daiichi sankyo tokyo japan/product/Daiichi Sankyo
    Average 86 stars, based on 1 article reviews
    s ketamine ketalar 200 mg 20 ml daiichi sankyo tokyo japan - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    s ketamine hydrochloride  (Pfizer Inc)
    86
    Pfizer Inc s ketamine hydrochloride
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    S Ketamine Hydrochloride, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s ketamine hydrochloride/product/Pfizer Inc
    Average 86 stars, based on 1 article reviews
    s ketamine hydrochloride - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    spravato s ketamine nasal spray  (Janssen)
    86
    Janssen spravato s ketamine nasal spray
    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment <t>with</t> <t>S-ketamine</t> (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).
    Spravato S Ketamine Nasal Spray, supplied by Janssen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/spravato s ketamine nasal spray/product/Janssen
    Average 86 stars, based on 1 article reviews
    spravato s ketamine nasal spray - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment with S-ketamine (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).

    Journal: bioRxiv

    Article Title: Antidepressants interact with sex steroid receptors and their intracellular signaling components

    doi: 10.64898/2026.03.17.712321

    Figure Lengend Snippet: Antidepressants rapidly activate ERα. (A) The relative change in ERα phosphorylation at Ser167 in MCF-7 cells compared with baseline control following treatment with S-ketamine (10 µM) and imipramine (10 µM) for 10 minutes. Phosphorylation levels were measured using a sandwich ELISA with luminescence readout. Estradiol (100 nM) served as the positive control for ERα activation. ( B) Inhibition of ERα by fulvestrant pretreatment eliminates antidepressant activation of ERα as measured by Ser167 phosphorylation. A 24-hour pretreatment of ERα with fulvestrant at 200 nM was followed by a 10-minute treatment while maintaining the concentration of ICI at 100 nM. Western blotting confirmed a lower amount of ERα protein after ICI pretreatment. ( C) MCF-7 cells were treated with S-ketamine (10 µM), imipramine (10 µM), or estradiol (100 nM) for 10 minutes. All treatments gave rise to an increase in the level of phosphorylated Ser167 compared to the baseline. Inhibition of membrane ERα by tunicamycin (15 µM for 30 min) prior to treatment with antidepressants and estradiol reduces the effect of antidepressants and estradiol. Western blotting exhibited no change in the amount of total ERα protein after pretreatment with tunicamycin. ( D) HSP27 in complex with ERα after pretreatment with tunicamycin (15 µM for 30 min) in various 10-minute treatment conditions. The levels of HSP27- ERα complex were measured using a sandwich ELISA with luminescence readout. Tunicamycin reduces the percentage of HSP27-ERα complex regardless of treatment conditions. The statistical significance is denoted as (ns: non-significant, *p < 0.05, **p < 0.01, *** p< 0.001, ****p < 0.0001).

    Article Snippet: Imipramine hydrochloride (Sigma-Aldrich, I7379), fluoxetine hydrochloride (LKT Labs, F4780), and S-ketamine (Pfizer, 2750 Ballerup, Denmark) were used as antidepressants and 17-β estradiol (Sigma-Aldrich, E2758) served as the positive control in the study.

    Techniques: Phospho-proteomics, Control, Sandwich ELISA, Positive Control, Activation Assay, Inhibition, Concentration Assay, Western Blot, Membrane

    Antidepressants selectively activate MAPK signaling and induce ERα-dependent gene expression in MCF-7 cells. (A) Quantification of MAPK phosphorylation (pMAPK/MAPK) by Western blot densitometry following treatment with vehicle, imipramine, S-ketamine, or estradiol (E2), in the presence or absence of the ERα degrader/antagonist fulvestrant and/or tunicamycin. Antidepressant treatment significantly increased MAPK phosphorylation, indicating enhanced MAPK pathway activation. (B) Total MAPK levels normalized to β-actin were unchanged across treatment conditions. Representative immunoblots for MAPK and pMAPK are shown above. (C) Quantification of Akt phosphorylation (pAkt/Akt) revealed no significant changes following antidepressant or E2 treatment, but there was a trend for a reduction by imipramine. (D) Total Akt levels normalized to β-actin were unaltered. Representative immunoblots for Akt and pAkt are shown above. One imipramine-treated sample was excluded from analysis due to an outlier pMAPK/MAPK ratio exceeding 1. Data from technical and biological replicates were pooled. (E–F) mRNA expression of the extranuclear-initiated ERα target gene LRRC54 (E) and the classical nuclear ERα target gene PgR (F) , quantified by qPCR following treatment with E2, imipramine, or S-ketamine. Antidepressants significantly increased LRRC54 and PgR expression, comparable to E2 and relative to vehicle control. Pretreatment with fulvestrant attenuated these effects, indicating ERα dependency. Data are presented as mean ± SEM from three independent biological replicates (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and ns as not significant.

    Journal: bioRxiv

    Article Title: Antidepressants interact with sex steroid receptors and their intracellular signaling components

    doi: 10.64898/2026.03.17.712321

    Figure Lengend Snippet: Antidepressants selectively activate MAPK signaling and induce ERα-dependent gene expression in MCF-7 cells. (A) Quantification of MAPK phosphorylation (pMAPK/MAPK) by Western blot densitometry following treatment with vehicle, imipramine, S-ketamine, or estradiol (E2), in the presence or absence of the ERα degrader/antagonist fulvestrant and/or tunicamycin. Antidepressant treatment significantly increased MAPK phosphorylation, indicating enhanced MAPK pathway activation. (B) Total MAPK levels normalized to β-actin were unchanged across treatment conditions. Representative immunoblots for MAPK and pMAPK are shown above. (C) Quantification of Akt phosphorylation (pAkt/Akt) revealed no significant changes following antidepressant or E2 treatment, but there was a trend for a reduction by imipramine. (D) Total Akt levels normalized to β-actin were unaltered. Representative immunoblots for Akt and pAkt are shown above. One imipramine-treated sample was excluded from analysis due to an outlier pMAPK/MAPK ratio exceeding 1. Data from technical and biological replicates were pooled. (E–F) mRNA expression of the extranuclear-initiated ERα target gene LRRC54 (E) and the classical nuclear ERα target gene PgR (F) , quantified by qPCR following treatment with E2, imipramine, or S-ketamine. Antidepressants significantly increased LRRC54 and PgR expression, comparable to E2 and relative to vehicle control. Pretreatment with fulvestrant attenuated these effects, indicating ERα dependency. Data are presented as mean ± SEM from three independent biological replicates (n = 3). Statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and ns as not significant.

    Article Snippet: Imipramine hydrochloride (Sigma-Aldrich, I7379), fluoxetine hydrochloride (LKT Labs, F4780), and S-ketamine (Pfizer, 2750 Ballerup, Denmark) were used as antidepressants and 17-β estradiol (Sigma-Aldrich, E2758) served as the positive control in the study.

    Techniques: Gene Expression, Phospho-proteomics, Western Blot, Activation Assay, Expressing, Control

    Time-dependent structural changes over 100 ns trajectories for ERα complexed with estradiol, imipramine, fluoxetine, S-ketamine, PaPE-1, and hydroxynorketamine (HNK). ( A ) Ligand root mean square deviation (RMSD) relative to the initial equilibrated structure, characterizing the stability and mobility of each compound within the binding pocket. ( B ) Protein backbone Cα RMSD, demonstrating the global structural integrity and stability of the receptor across all systems. ( C ) Cα root mean square fluctuation (RMSF) per residue, illustrating local protein flexibility and conserved dynamic patterns across the ligand-binding domain. ( D ) Radius of gyration (Rg) and its principal components (X, Y, Z), representing the maintenance of global structural compactness and shape. ( E ) Solvent accessible surface area (SASA) of the protein–ligand complexes, indicating stable exposure of the receptor-ligand surface throughout the simulation. ( F ) Visual representation of comparative binding free energies for the compounds based on MM/PBSA and MM/GBSA methods.

    Journal: bioRxiv

    Article Title: Antidepressants interact with sex steroid receptors and their intracellular signaling components

    doi: 10.64898/2026.03.17.712321

    Figure Lengend Snippet: Time-dependent structural changes over 100 ns trajectories for ERα complexed with estradiol, imipramine, fluoxetine, S-ketamine, PaPE-1, and hydroxynorketamine (HNK). ( A ) Ligand root mean square deviation (RMSD) relative to the initial equilibrated structure, characterizing the stability and mobility of each compound within the binding pocket. ( B ) Protein backbone Cα RMSD, demonstrating the global structural integrity and stability of the receptor across all systems. ( C ) Cα root mean square fluctuation (RMSF) per residue, illustrating local protein flexibility and conserved dynamic patterns across the ligand-binding domain. ( D ) Radius of gyration (Rg) and its principal components (X, Y, Z), representing the maintenance of global structural compactness and shape. ( E ) Solvent accessible surface area (SASA) of the protein–ligand complexes, indicating stable exposure of the receptor-ligand surface throughout the simulation. ( F ) Visual representation of comparative binding free energies for the compounds based on MM/PBSA and MM/GBSA methods.

    Article Snippet: Imipramine hydrochloride (Sigma-Aldrich, I7379), fluoxetine hydrochloride (LKT Labs, F4780), and S-ketamine (Pfizer, 2750 Ballerup, Denmark) were used as antidepressants and 17-β estradiol (Sigma-Aldrich, E2758) served as the positive control in the study.

    Techniques: Binding Assay, Residue, Ligand Binding Assay, Solvent